Toujeo and GLP-1 medications sit in completely different categories despite their surface-level similarities
Sarwar Alam Chaudhary Registered Pharmacist, BHMS Scholar Reviewed Official Prescribing Label Warning Tirzepatide (Mounjaro / Zepbound) can cut oral birth control absorption by ~60% The manufacturers own label recommends switching to a non-oral contraceptive, or adding a barrier method, for 4 weeks after starting tirzepatide and after every dose increase
in relation to their weight-loss and diabetes medications: Ozempic (semaglutide) [2018] Rybelsus (semaglutide) [2020] Wegovy (semaglutide) [2021] Mounjaro (tirzepatide) [2022] Trulicity (dulaglutide) [2022] Saxenda (liraglutide) [2015] Victoza (tirzepatide) [2010] The proposed class action is based on allegations that these drugs have improperly disclosed or failed to warn about certain side effects such as: - Gastroparesis / stomach paralysis - Gastric statis - Ileus - Gastric obstruction - Intestinal obstruction These medical conditions often lead to hospitalization, surgery, and vomiting for extended lengths of time
Can I stop taking these medications once I reach my goal weight
Helps Patients Qualify And Succeed With GLP-1 At TrimBody M.D., patients receive medical evaluations, lab testing, and ongoing support to safely qualify for GLP-1 therapy